L
Lexaria Bioscience Corp D
D
LEXX
2.29000
USD
0.06
(2.69%)
مغلق
حجم التداول
5,960
الربح لكل سهم
0
العائد الربحي
0
P/E
-5
حجم السوق
36,205,369
المقالات
العنوان: Lexaria Bioscience Corp
القطاع: Healthcare
الصناعة: Biotechnology
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.